Detalles de la búsqueda
1.
Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.
PLoS One;
17(2): e0264628, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35213675
2.
Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study.
Rheumatology (Oxford);
50(12): 2197-205, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21984763
3.
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
PLoS One;
16(6): e0253793, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34170978
4.
Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression.
J Pathol Clin Res;
4(3): 193-203, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29624903
5.
The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study.
Arthritis Res Ther;
18: 44, 2016 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26860519
6.
Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study.
Lupus Sci Med;
1(1): e000007, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25396058
Resultados
1 -
6
de 6
1
Próxima >
>>